Distinguishing glioblastoma progression from treatment-related changes using DTI directionality growth analysis.

Rik van den ElshoutB AriënsM EsmaeiliB AkkurtM MannilF J A MeijerA G van der KolkT W J ScheenenD Henssen

Published in: Neuroradiology (2024)

Based on our results, quantifying posttreatment contrast-enhancing lesion development directionality with DTI in glioblastoma patients does not appear to effectively distinguish between TP and TRA.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
magnetic resonance
prognostic factors
peritoneal dialysis
magnetic resonance imaging
patient reported outcomes
combination therapy